Allurion Technologies and Compute Health Acquisition Corp. remind Compute Health’s stockholders to vote in favor of their previously announced proposed business combination at a Special Meetin for stockholders of record as of July 3, 2023. All Compute Health stockholders, regardless of number of shares held, are encouraged to vote “FOR” the Business Combination and related proposals described in the definitive proxy statement and prospectus previously filed by the parties with the U.S. Securities and Exchange Commission in connection with the Special Meeting. If the relevant proposals at the Special Meeting are approved, the parties anticipate that the Business Combination will close shortly thereafter, subject to the satisfaction of all other closing conditions. Following the closing of the Business Combination, Allurion Technologies Holdings, Inc., a wholly-owned subsidiary of Allurion and the surviving corporation following the consummation of the Business Combination, is expected to be listed on the New York Stock Exchange under the name “Allurion Technologies, Inc.,” with its common stock trading under the new ticker symbols “ALUR.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>